ClinicalTrials.Veeva

Menu

Differing Levels of Positive Anti-Neutrophil Cytoplasm Antibody (ANCA) Test and Their Correlation With Vasculitis or Malignancy or Chronic Inflammation

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Treatments

Other: Follow-up

Study type

Observational

Funder types

Other

Identifiers

NCT02180126
HYMC0041-14

Details and patient eligibility

About

A positive Anti-Neutrophil Cytoplasm Antibody (ANCA) test administered to patients with a high probability for vasculitis has high sensitivity and specificity for vasculitis. A positive ANCA test result in those patients who do not have a high probability for vasculitis requires extensive follow-up because those patients eventually present with malignancy or other inflammatory diseases. The investigators wish to investigate the correlation between the differing levels of positive ANCA tests and their relationship to vasculitis, malignancy and inflammatory diseases.

Enrollment

160 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with borderline positive ANCA test results

Exclusion criteria

  • Pregnant

Trial design

160 participants in 1 patient group

Positive ANCA
Description:
Patients with borderline positive ANCA results.
Treatment:
Other: Follow-up

Trial contacts and locations

1

Loading...

Central trial contact

Tatiana Sivan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems